about
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumoursSimvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and NeckCetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation: a preclinical rationale for maintenance treatment after radiotherapyThe use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis.Oligosaccharyltransferase inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity.Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsNeuregulin Signaling Is a Mechanism of Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma
P50
Q34283737-A590767D-AB94-4958-9F43-6330D7A0868EQ34369305-330C21FF-C9D4-4E13-BE15-B625E0CD22D7Q39509472-3497506F-83FF-4AE4-A241-ABDD8F5D935CQ41954705-7F134EFD-9D86-443B-8602-AFA19C6D16ABQ55456695-AFF53365-5964-430B-BAAA-47F04B6FF829Q90349512-4650EFDE-1037-43C0-94D8-C133E3E27D05Q92459556-5957E512-2CA9-4677-8907-0D2F487F543B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Marta Baro
@en
Marta Baro
@nl
type
label
Marta Baro
@en
Marta Baro
@nl
prefLabel
Marta Baro
@en
Marta Baro
@nl
P108
P31
P496
0000-0002-6019-0534